Follow Us

       


"Like" us on Facebook

Clinical Trials

Disease or Condition
Cancer - Hodgkin Lymphoma
Title
Phase 3 Frontline Therapy Trial in Patients With Advanced Classical Hodgkin Lymphoma
Description
A Randomized, Open-Label, Phase 3 Trial of A+AVD vs ABVD as Front-line Therapy in Patients with Advanced Classical Hodgkin Lymphoma.
(C25003)
IRB Number
NCT01712490
Inclusion/Notes

Please contact the research department for full eligibility details. For additional information, please click here: http://clinicaltrials.gov/ct2/show/NCT01712490

Status
Open to Enrollment
Principal Investigator
Daniel R Greenwald, MD
Contact Email
research@ccsb.org
Phone
(805) 898-2117

This is the fat footer - edit page 906 to add content.